Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00122629
Status:
TERMINATED
Last Update Posted:
2005-07-29
First Post:
2005-07-20
Brief Title:
Triple Therapy With Peg-Interferon Alfa-2bRibavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2bRibavirin for Previous Hepatitis C Virus HCV Non Responders
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
French National Agency for Research on AIDS and Viral Hepatitis
Organization Data
Organization:
French National Agency for Research on AIDS and Viral Hepatitis
Class:
OTHER_GOV
Study ID:
ANRSHC03 BITRI
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Schering-Plough | INDUSTRY |